PBS expands kidney drug access

6 minute read


An estimated 70,000 Australians are set to benefit as the expanded listing targets soaring rates of kidney failure and hospitalisation.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×